Tytuł artykułu
Wybrane pełne teksty z tego czasopisma
Identyfikatory
Warianty tytułu
Języki publikacji
Abstrakty
SZJ-1207 is an antidepressant natural product with a steroidal structure extracted from Stephanotis mucronata. It is a novel antidepressant candidate molecule and all its pharmacokinetic properties have not been reported. In this pharmacokinetic study in mice following oral administration, an accurate and sensitive UPLC-MS/MS method was established and evaluated to measure SZJ-1207 concentrations in mouse plasma and brain samples. The results provide information regarding the pharmacokinetics of SZJ-1207 as a potential antidepressant.
Słowa kluczowe
Czasopismo
Rocznik
Tom
Strony
99--105
Opis fizyczny
Bibliogr. 27 poz., rys., wykr.
Twórcy
autor
- Zhejiang Key Laboratory of Neuropsychiatric Drug Research, Hangzhou Medical College, 182 Tianmushan Road, Hangzhou 310013, Zhejiang, China
autor
- Zhejiang Key Laboratory of Neuropsychiatric Drug Research, Hangzhou Medical College, 182 Tianmushan Road, Hangzhou 310013, Zhejiang, China
autor
- Zhejiang Key Laboratory of Neuropsychiatric Drug Research, Hangzhou Medical College, 182 Tianmushan Road, Hangzhou 310013, Zhejiang, China
autor
- Zhejiang Key Laboratory of Neuropsychiatric Drug Research, Hangzhou Medical College, 182 Tianmushan Road, Hangzhou 310013, Zhejiang, China
autor
- Zhejiang Key Laboratory of Neuropsychiatric Drug Research, Hangzhou Medical College, 182 Tianmushan Road, Hangzhou 310013, Zhejiang, China
autor
- Zhejiang Key Laboratory of Neuropsychiatric Drug Research, Hangzhou Medical College, 182 Tianmushan Road, Hangzhou 310013, Zhejiang, China
autor
- Zhejiang Key Laboratory of Neuropsychiatric Drug Research, Hangzhou Medical College, 182 Tianmushan Road, Hangzhou 310013, Zhejiang, China
Bibliografia
- 1. Anyfanti, P.; Gavriilaki, E.; Pyrpasopoulou, A.; Triantafyllou, G.; Triantafyllou, A.; Chatzimichailidou, S.; Gkaliagkousi, E.; Aslanidis, S.; Douma, S. Clin. Rheumatol. 2016, 35, 733–9.
- 2. Ishikawa, H.; Kawakami, N.; Kessler, R. C. Epidemiol. Psychiatr. Sci. 2016, 25, 217–29.
- 3. Hasin, D. S.; Sarvet, A. L.; Meyers, J. L.; Saha, T. D.; Ruan, W. J.; Stohl, M.; Grant, B. F. JAMA Psychiatry 2018, 75, 336–46.
- 4. Huang, Y.; Wang, Y.; Wang, H.; Liu, Z.; Yu, X.; Yan, J.; Yu, Y.; Kou,C.; Xu, X.; Lu, J.;Wang, Z.; He, S.; Xu,Y.; He, Y.; Li,T.;Guo, W.; Tian, H.; Xu, G.; Xu, X.; Ma, Y.; Wang, L.; Wang, L.; Yan, Y.; Wang, B.; Xiao, S.; Zhou, L.; Li, L.; Tan, L.; Zhang, T.; Ma, C.; Li, Q.; Ding, H.; Geng, H.; Jia, F.; Shi, J.; Wang, S.; Zhang, N.; Du, X.; Du, X.; Wu, Y. Lancet Psychiatry 2019, 6, 211–24.
- 5. Trivedi, M. H.; Rush, A. J.; Wisniewski, S. R.; Nierenberg, A. A.; Warden, D.; Ritz, L.; Norquist, G.; Howland, R. H.; Lebowitz, B.; McGrath, P. J.; Shores-Wilson, K.; Biggs, M. M.; Balasubramani, G. K.; Fava, M. Am. J. Psychiatry 2006, 163, 28–40.
- 6. Domenici, E.; Willé, D. R.; Tozzi, F.; Prokopenko, I.; Miller, S.; McKeown, A.; Brittain, C.; Rujescu, D.; Giegling, I.; Turck, C. W.; Holsboer, F.; Bullmore, E. T.; Middleton, L.; Merlo-Pich, E.; Alexander, R. C.; Muglia, P. PLoS One 2010, 5, e9166.
- 7. Oliva, V.; Lippi, M.; Paci, R.; Del Fabro, L.; Delvecchio, G.; Brambilla, P.; De Ronchi, D.; Fanelli, G.; Serretti, A. Prog. Neuropsychopharmacol. Biol. Psychiatry 2021, 109, 110266.
- 8. Yeung, K. S.; Hernandez, M.; Mao, J. J.; Haviland, I.; Gubili, J. Phytother Res. 2018, 32, 865–91.
- 9. Zhang, Y.; Long, Y.; Yu, S.; Li, D.; Yang, M.; Guan, Y.; Zhang, D.; Wan, J.; Liu, S.; Shi, A.; Li, N.; Peng, W. Pharmacol. Res. 2021, 164, 105376.
- 10. Li, J.-M.; Zhao, Y.; Sun, Y.; Kong, L.-D. J. Ethnopharmacol 2020, 257, 112830.
- 11. Zirak, N.; Shafiee, M.; Soltani, G.; Mirzaei, M.; Sahebkar, A. J. Cell Physiol 2019, 234, 8496–508.
- 12. Shafiee, M.; Arekhi, S.; Omranzadeh, A.; Sahebkar, A. J. Affect Disord. 2018, 227, 330–7.
- 13. Chong, P. S.; Fung, M.-L.; Wong, K. H.; Lim, L. W. Int. J. Mol. Sci. 2019, 21.
- 14. Du, H.; Wang, K.; Su, L.; Zhao, H.; Gao, S.; Lin, Q.; Ma, X.; Zhu, B.; Dong, X.; Lou, Z. J. Pharm. Biomed. Anal. 2016, 128, 469–79.
- 15. Cao, L.-H.; Zhao, Y.-Y.; Bai,M.; Geliebter, D.; Geliebter, J.; Tiwari, R.; He, H.-J.; Wang, Z.-Z.; Jia, X.-Y.; Li, J.; Li, X.-M.; Miao, M.-S. Front. Pharmacol. 2022, 13, 838261.
- 16. Zhang, J.-H.; Yang, H.-Z.; Su, H.; Song, J.; Bai, Y.; Deng, L.; Feng, C.-P.; Guo, H.-X.; Wang, Y.; Gao, X.; Gu, Y.; Zhen, Z.; Lu, Y. Am. J. Chin. Med. 2021, 49, 1195–213.
- 17. Xie, W.; Meng, X.; Zhai, Y.; Zhou, P.; Ye, T.; Wang, Z.; Sun, G.; Sun, X. Molecules 2018, 23.
- 18. Kanes, S.; Colquhoun, H.; Gunduz-Bruce, H.; Raines, S.; Arnold, R.; Schacterle, A.; Doherty, J.; Epperson, C. N.; Deligiannidis, K. M.; Riesenberg, R.; Hoffmann, E.; Rubinow, D.; Jonas, J.; Paul, S.; Meltzer-Brody, S. Lancet (London, England) 2017, 390, 480–9.
- 19. Beurel, E.; Toups, M.; Nemeroff, C. B. Neuron 2020, 107, 234–56.
- 20. Hao, S.-J.; Gao, L.-J.; Xu, S.-F.; Ye, Y.-P.; Li, X.-Y. Nat. Product. Commun. 2018, 13, 531–2.
- 21. Yiping, Y.; Xiaoyu, L.; Yewei, Y.; Zhengrong, Z.; Fengyang, C.; Shifang, X.; Wenhai, H. Application of antidepressant compound In preparation of antidepressant drugs and antidepressant health-care foods. US2018177801. 2018.
- 22. Alavijeh, M. S.; Chishty, M.; Qaiser, M. Z.; Palmer, A. M. NeuroRx : J. Am. Soc. Exp. NeuroTherapeutics 2005, 2, 554–71.
- 23. Straehla, J. P.; Warren, K. E. Pharmaceutics 2020, 12, 948.
- 24. Arnott, J. A.; Planey, S. L. Expert Opin. Drug Discov. 2012, 7, 863–75.
- 25. Liu, X.; Chen, C. Curr. Opin. Drug Discov. Dev. 2005, 8, 505–12.
- 26. Hammarlund-Udenaes, M.; Fridén, M.; Syvänen, S.; Gupta, A. Pharm. Res. 2008, 25, 1737–50.
- 27. Wu, S.; Yin, Y.; Du, L. Cell Mol. Neurobiol. 2022, 42, 2571–91.
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-f81a2966-9c13-4a02-a530-629e95d52362